Vaccine campaign begins amid virus surge in rebel-held Syria

Syria has been divided by the war so vaccinations in government-controlled areas, nearly 60% of the country's territory, take place separately

May 02, 2021 11:23 am | Updated 11:24 am IST - IDLIB, Syria

The AstraZeneca vaccines were delivered to the rebel-controlled area through a border crossing with Turkey, the northwestern territory’s only gateway to the outside world.

The AstraZeneca vaccines were delivered to the rebel-controlled area through a border crossing with Turkey, the northwestern territory’s only gateway to the outside world.

A COVID-19 vaccine campaign kicked off in Syria’s last rebel-held enclave on Saturday, with a 45-year-old front-line nurse becoming the first to receive a U.N.-secured jab.

Nizar Fattouh, a nurse in Ibn Sina Hospital in Idlib city, received one of 53,800 AstraZeneca vaccines delivered to northwest Syria through Turkey on April 21.

The vaccines come amid a new surge of infections in the war-torn country. Syria's supplies of oxygen are depleted and its hospitals were already overwhelmed from 10 years of conflict and deteriorating health care services.

The AstraZeneca vaccines were delivered to the rebel-controlled area through a border crossing with Turkey, the northwestern territory’s only gateway to the outside world.

Idlib health official Yasser Najib said the jabs were provided through the U.N.-led COVAX program for the world’s poor and developing nations.

Also Read | Comment | What Israel wants in Syria

He said the vaccination campaign will last 21 working days, starting Saturday in two of the enclave's largest hospitals. On Monday, the campaign will unfold in other health centers, Najib said.

He said the small quantity of doses means prioritizing health care workers and aid personnel who are on the front line of the battle against the coronavirus. Infections among health care workers in the enclave have been high, accounting for as much as 30% of confirmed cases at one point.

There are over 21,000 confirmed infections in rebel-held Idlib province, home to 4 million people, most of them displaced from different parts of Syria by the conflict. At least 641 have died in the area from COVID-19 related complications. Conflict has subsided in the area, but outbreaks of violence are still reported.

Syria has been divided by the war so vaccinations in government-controlled areas, nearly 60% of the country's territory, take place separately.

The Syrian government has secured 200,000 vaccines through the U.N.-led program but also has obtained doses from China, Russia and the United Arab Emirates. A limited inoculation campaign had also begun in government-controlled areas that are experiencing increased pressure on hospitals.

Also Read | First woman ever applies to run for President of Syria

In the Kurdish-controlled northeast, authorities announced this week they will extend a partial lockdown amid a surge in infections. The one-week extension comes as an international aid group warned of oxygen shortages in the region.

Northeastern Syria, administered by a Kurdish-led authority, doesn’t have a separate inoculation program and is dependent on Damascus for testing for the virus and for vaccinations. The local health department reported 123 new cases and 14 deaths in the region, which is home to nearly 4 million people and borders Turkey and Iraq. The new cases raise to nearly 15,800 the total registered coronavirus cases in the region, including 571 deaths.

The World Health Organization has said the vaccination campaign in Syria aims to inoculate 20% of the total population residing in the country by the end of the year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.